Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 216, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: The invention relates to a peptide comprising an amino acid sequence selected from the group consisting of (i) SEQ ID NO: 1 to SEQ ID NO: 113, and (ii) a variant sequence thereof which maintains capacity to bind to MHC molecule(s) and/or induce T cells cross-reacting with said variant peptide, or a pharmaceutically acceptable salt thereof.

Abstract: A high-frequency circuit including a circuit board which bears at least one electronic component and a conductor structure, and including a waveguide structure manufactured separately from the circuit board. The waveguide structure is positioned on the circuit board in such a way that high-frequency signals are transferable between the conductor structure on the circuit board and the waveguide structure. The waveguide structure is held with the aid of press-fit pins on the circuit board.

Abstract: A method for estimating a speed of a radar target using a radar sensor, in particular a radar sensor for motor vehicles, on the basis of signals that are contained in respective evaluation channels that correspond to different center antenna positions of relevant transmitting and receiving antennas in a direction, having the steps: determining, for the various evaluation channels, a respective individual radial speed assigned to the respective evaluation channel, of the radar target; and estimating a speed of the radar target based on the determined individual radial speeds of the radar target, the speed including information about a tangential speed; and a radar sensor for carrying out the method.

Abstract: A radar sensor is described. The radar sensor includes at least two synchronously operating high frequency components, which each have at least one signal path in which the phase of the transmitted high frequency signal is varied by a temperature-dependent phase difference. In each high frequency component, a phase detector is connected in parallel to the signal path, which supplies a signal that assumes an extremum at a certain phase difference independently of the temperature, and a phase shifter is situated in the signal path, ith the aid of which the phase difference is settable in such a way that the signal of the phase detector assumes the extremum.

Abstract: A MIMO radar sensor for motor vehicles, having an antenna assemblage on a rectangular circuit board whose edges define a y direction and a z direction. The antenna assemblage includes at least two arrays of transmitting antennas and at least two arrays of receiving antennas. Transmitting antennas within each array are offset from one another in a z direction, and the two arrays of the transmitting antennas are offset from one another in a y direction. The receiving antennas within each array are offset from one another in a y direction, and the two arrays of the receiving antennas are offset from one another in a z direction. A high-frequency module is disposed in a central region of the circuit board between the arrays of the transmitting and receiving antennas.

Abstract: An improved evaluation of radar signals, in particular radar signals received by a Uniform Linear Array (ULA) antenna. Through the application of a plurality of different beamformings to the radar signals, drops in the gain can be compensated by the beamforming.

Abstract: An evaluation device for at least one radar sensor having an electronic unit which is designed to evaluate measuring signals of the radar sensor. The radar sensor is designed in such a way that, during its measuring cycles, it emits radar signals and to receive radar signals reflected from an area surrounding the radar sensor and outputs signals corresponding to the received reflected radar signals as measuring signals, while the radar sensor remains inactive for a predetermined pause time between two successive measuring cycles. The electronic unit is designed to perform a Fourier transform utilizing measuring signals from at least two different measuring cycles and/or utilizing evaluation signals derived from the measuring signals from at least two different measuring cycles. A corresponding method for evaluating at least one radar sensor is also described.

Abstract: An antenna device. The antenna device includes a carrier element having at least one first strip conductor and having a second strip conductor; at least one fastening structure, which is formed in or on the carrier element; at least one antenna element, which is arranged or fastened on or in the fastening structure and is connected to the strip conductor; a transmitter device, which is arranged on the carrier element and is connected to the second strip conductor, and is designed to transmit a transmitter signal to the at least one antenna element and/or to receive a transmitter signal from the at least one antenna element.